Skip to content

13F-HR filed by ANDERA PARTNERS

ANDERA PARTNERS filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-10-16 20:45:08 UTC, with 7 holding rows worth $175,700,568.

Accession
0001757283-26-000022
Filed
2026-10-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 7 entries on the cover page, a total value of $175,700,568 stated on the cover page (in dollars after the unit check, H1), rows summing to $175,700,568 with VALUE read as dollars as filed, 13F file number 028-26561. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
KESTRA MED TECHNOLOGIES LTDG52441105SHS2,728,679$77,194,329dollars as filed
MINERALYS THERAPEUTICS INC603170101COM1,591,917$40,004,874dollars as filed
AVALYN PHARMA INC05348Y105COMMON STOCK929,824$26,490,686dollars as filed
AGOMAB THERAPEUTICS NV00860C102SPONSORED ADS1,538,702$17,079,592dollars as filed
INVENTIVA SA46124U107ADS3,633,181$13,406,438dollars as filed
EVOMMUNE INC30054Y107COMMON STOCK97,362$804,210dollars as filed
NYXOAH S AB6S7WD106SHS522,057$720,439dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001757283-26-000022this filing2026-10-16